Caina Technology Co

Caina Technology Co Current Assets

The Current Assets of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 106.19 M CNY. In the previous year, Current Assets was 1.14 B CNY — a change of -90.68% (lower).

Current Assets

106.19 MCNY

YoY

-90.68%

Last updated:

Current Assets of Caina Technology Co is 2025 106.19 M CNY. Current Assets of Caina Technology Co was 2024 1.14 B CNY. It decreases by -90.68% lower compared to the previous year.

The Caina Technology Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
88.67 M CNY
Jan 1, 2019
101.02 M CNY
Jan 1, 2020
236.95 M CNY
Jan 1, 2021
326.77 M CNY
Jan 1, 2022
1.40 B CNY
Jan 1, 2023
1.33 B CNY
Jan 1, 2024
1.14 B CNY
Jan 1, 2025
106.19 M CNY
The Caina Technology Co Current Assets history
YEARCurrent AssetsYoY
106.19 MCNY-90.68%
1.14 BCNY-14.33%
1.33 BCNY-4.97%
1.40 BCNY+328.52%
326.77 MCNY+37.91%
236.95 MCNY+134.55%
101.02 MCNY+13.93%
88.67 MCNY+132.06%
38.21 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Current Assets of Caina Technology Co is 106.19 M CNY in 2025.

Current Assets of Caina Technology Co changed from 1.14 B CNY to 106.19 M CNY, representing a -90.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Caina Technology Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Caina Technology Co

All Key Metrics — Caina Technology Co